ConductScience.org, home

Trial · NCT03482479

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

NCT03482479, Phase 2, Completed, University of Pennsylvania

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis. Trials, record NCT03482479. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03482479

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
NCT number
NCT03482479
Status
Completed
Phases
Phase 2
Enrollment
60 participants, actual
Lead sponsor
University of Pennsylvania
Conditions
Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis, Granulomatosis With Polyangiitis, Microscopic Polyangiitis, Polyarteritis Nodosa, Takayasu Arteritis
Interventions
Naltrexone Hydrochloride, Placebo Comparator
First posted
2018-03-29
Last updated
2026-01-22

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPROMIS Global Physical HealthWeek 12.Questionnaire about improved health related quality of life to a greater extent than placebo.
SecondaryPROMIS Global Physical Health9 weeksQuestionnaire about improved health related quality of life to a greater extent than placebo.
SecondarySF-36 (physical component subscore)12 weeksHealth related quality of life measured by a questionnaire.
SecondaryPROMIS Questionnaires12 weeks
Questions will ask about anxiety, depression, and sleep disturbance on the PROMIS short form, PROMIS Global Mental Health, and on PROMIS-CAT will ask about physical function, fatigue, satisfaction with social roles, and pain interference, as well in the pain intensity item.
SecondaryClinical Global Impression of Severity (CGI-S)12 weeks7-point scale of patients' self-reporting of severity during the study.
SecondaryClinical Global Impression of Improvement (CGI-I)12 weeks7-point scale of patients' self-reporting of severity during the study.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03482479

GET https://conductscience.org/api/trials/v1/NCT03482479/registered